Article Information
History
- May 2, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Maia Norman*,1,2,3,
- Tal Gilboa*,1,2,4,
- Alana F. Ogata1,2,4,
- Adam M. Maley1,2,4,
- Limor Cohen1,2,5,
- Yongfei Cai6,
- Jun Zhang6,
- Jared E. Feldman7,
- Blake M. Hauser7,
- Timothy M. Caradonna7,
- Bing Chen6,8,
- Aaron G. Schmidt7,9,
- Galit Alter7,
- Richelle C. Charles10,11,
- Edward T. Ryan10,11,12 and
- David R. Walt1,2,4,#
- 1Department of Pathology, Brigham and Women’s Hospital, Boston, MA
- 2Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA
- 3Tufts University School of Medicine, Boston, MA
- 4Harvard Medical School, Boston, MA
- 5Department of Chemical Biology, Harvard University, Boston, MA
- 6Division of Molecular Medicine, Boston Children’s Hospital, Boston, MA
- 7Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
- 8Department of Pediatrics, Harvard Medical School, Boston, MA
- 9Department of Microbiology, Harvard Medical School, Boston, MA
- 10Division of Infection Diseases, Massachusetts General Hospital, Boston, MA
- 11Department of Medicine, Harvard Medical School, Boston, MA
- 12Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA
- ↵#Corresponding author, email: dwalt{at}bwh.harvard.edu
↵* Authors contributed equally to this work
Posted May 02, 2020.
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients
